Cargando…
Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported Adequately
PURPOSE: Two-stage single-arm designs have historically been the most common design used in phase II oncology. They remain a mainstay today, particularly for trials in rare subgroups. Consequently, it is imperative such studies be designed, analyzed, and reported effectively. We comprehensively revi...
Autores principales: | Grayling, Michael J., Mander, Adrian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691516/ https://www.ncbi.nlm.nih.gov/pubmed/34950839 http://dx.doi.org/10.1200/PO.21.00276 |
Ejemplares similares
-
Re-formulating Gehan’s design as a flexible two-stage single-arm trial
por: Grayling, Michael J., et al.
Publicado: (2019) -
Do single‐arm trials have a role in drug development plans incorporating randomised trials?
por: Grayling, Michael J., et al.
Publicado: (2015) -
An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018) -
A stochastically curtailed single-arm phase II trial design for binary outcomes
por: Law, Martin, et al.
Publicado: (2022) -
A stochastically curtailed two-arm randomised phase II trial design for binary outcomes
por: Law, Martin, et al.
Publicado: (2021)